Navigation Links
QIAGEN Significantly Expands its Offering of Assay Panels for Next-generation Sequencing (NGS) Complemented by Ingenuity Analysis and Interpretation Capabilities
Date:6/7/2013

GERMANTOWN, Maryland and HILDEN, Germany, June 7, 2013 /PRNewswire/ --


  • Expansion to about 20 validated gene panels will offer customers new opportunities for targeted clinical sequencing in a growing range of indications in cancer and other diseases
  • Driving adoption through ease of use, quality of results and compatibility with existing NGS workflows as well as with QIAGEN NGS platform now in development
  • Integration of Ingenuity Knowledge Base greatly enhances ease and depth of NGS data interpretation, seen as key bottleneck to NGS adoption in clinical research and diagnostics

QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced plans to significantly expand its existing portfolio of molecular assays used in next-generation sequencing (NGS) during 2013 as part of its expansion into this fast-growing market and ambitions to provide an ecosystem of products and services designed to drive greater use of this breakthrough technology in clinical research and diagnostics.

QIAGEN is exhibiting its NGS products at the European Society of Human Genetics Conference from June 8-11 in Paris.

The current portfolio of nine GeneRead™ DNAseq panels launched in late 2012 is being expanded to approximately 20 during the course of 2013. QIAGEN is leveraging its deep molecular content and assay portfolio to create these new gene panels for targeted NGS analysis based on the GeneGlobe portfolio of more than 60,000 annotated molecular assays. Initial customer demand has been very strong for these products, which are "universal" and are designed to be used on any NGS platform, and also to integrate seamlessly into the sample-to-result NGS workflow that includes the QIAGEN GeneRe
'/>"/>

SOURCE Qiagen N.V.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. QIAGEN Expands Pipeline of Promising New Biomarkers for Development of Personalized Healthcare Companion Diagnostics
2. QIAGEN Enters Into Broad Collaboration Agreement With Lilly for the Development and Commercialization of Companion Diagnostics
3. QIAGEN Kicks Off Next-Generation Sequencing Initiative With Launch of a Series of Consumable Products to Improve NGS Workflows
4. QIAGEN Achieves Personalized Healthcare Milestone with U.S. Approval of Companion Diagnostic for Colorectal Cancer
5. QIAGEN Unveils Initiative to Create Next-Generation Sequencing Portfolio for use in Clinical Research and Molecular Diagnostics
6. QIAGEN and Cardinal Health Collaborate to Offer Molecular Diagnostic Products to Smaller and Mid-sized U.S. Hospitals
7. For Multiple Sclerosis Treatment, Prescriber Base for Genzymes Aubagio Among U.S. Neurologists Has Increased Significantly at Six Months Post-launch, Compared to One and Three Months Post-launch
8. First Large-Scale Population-Based Study in the U.S. Shows Hologics 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection
9. Hemodialysis Patient Share for Sanofis Ferrlecit Increased Significantly in the First Quarter of 2013 Compared to the Previous Quarter
10. Isis Publishes Data Demonstrating Antisense Targeting of ApoC-III Significantly Reduces ApoC-III and Triglycerides
11. Novartis Reports Omalizumab Significantly Improved Chronic Idiopathic Urticaria Symptoms in Patients Who Failed Standard Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2014)... - New Solution That Makes ... JIN Co., Ltd. will launch JINS MEME "ACADEMIC PACK" ... yen or $5,000 (without tax /including two pairs of JINS ... a dedicated solution of "JINS MEME" to academic researchers, and ... generated by electrooculography and six-axis sensors without API. (*Physiological data ...
(Date:11/26/2014)... SAN DIEGO , Nov. 26, 2014  Aethlon ... into a definitive agreement to raise approximately $3.3 million ... is being made by one institutional healthcare focused investor. Each ... one-fifth of a common share purchase warrant. Each whole ... at a price of $0.30 for a period of ...
(Date:11/26/2014)... Nov. 26, 2014  Genomic Health, Inc. (Nasdaq: ... Chairman, Chief Executive Officer and President, will participate in ... at The New York Palace Hotel in ... 11:30 am Eastern Time (ET). To access ... call, go to the  Investor Relations  section of the ...
Breaking Medicine Technology:JIN to Launch JINS MEME ACADEMIC PACK in Late April 2015 2JIN to Launch JINS MEME ACADEMIC PACK in Late April 2015 3Aethlon Medical Announces $3.3 Million Equity Investment 2Aethlon Medical Announces $3.3 Million Equity Investment 3Genomic Health to Present at the 26th Annual Piper Jaffray Healthcare Conference 2Genomic Health to Present at the 26th Annual Piper Jaffray Healthcare Conference 3
... 4, 2010 /PRNewswire / -- Streamline Health ... provider of document workflow solutions for hospitals, today announced ... delivery systems in the United States, will implement Streamline ... The solution provides an automated ...
... Syringe Locking-Device Technology at HealthAchieve Conference -- JERUSALEM, November 4, 2010 ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... var shortURL = ""; BitlyCB.alertResponse = function(data) { var s = ,; var first_result; // Results are ...
Cached Medicine Technology:Texas-Based Hospital Expands Utilization of Streamline Health Document Workflow Solutions 2Texas-Based Hospital Expands Utilization of Streamline Health Document Workflow Solutions 3Texas-Based Hospital Expands Utilization of Streamline Health Document Workflow Solutions 4Medisafe 1 Technologies to Present Syringe Locking-Device Technology at HealthAchieve Conference 2Medisafe 1 Technologies to Present Syringe Locking-Device Technology at HealthAchieve Conference 3Medisafe 1 Technologies to Present Syringe Locking-Device Technology at HealthAchieve Conference 4Medisafe 1 Technologies to Present Syringe Locking-Device Technology at HealthAchieve Conference 5Medisafe 1 Technologies to Present Syringe Locking-Device Technology at HealthAchieve Conference 6Medisafe 1 Technologies to Present Syringe Locking-Device Technology at HealthAchieve Conference 7Medisafe 1 Technologies to Present Syringe Locking-Device Technology at HealthAchieve Conference 8
(Date:11/27/2014)... PA (PRWEB) November 27, 2014 ... volunteer Aria Health employees, prepared and donated 200 ... the Lutheran Settlement House , a non-profit, community-based ... families living in Philadelphia. The dinners were assembled ... House Senior Center, and distributed to vulnerable low ...
(Date:11/27/2014)... The Little Gym, we know that being active provides ... a recent study confirmed that regular physical activity can ... Pediatrics found that “Promoting physical activity that involves ... may be important not only for health, but also ... of children; those that were engaging in regular physical ...
(Date:11/27/2014)... Delhi, India (PRWEB) November 27, 2014 ... has announced a search engine optimization service just ... small businesses or start-ups cannot afford costly search ... this service package, keeping their affordablity and requirements ... the service cost, but it has not compromised ...
(Date:11/27/2014)... California (PRWEB) November 27, 2014 The ... You An Up-Close Look At This Year’s Entries | ... An All-Inclusive Stay For Two At Their Resort, Pure ... Times events or L.A.-based Hempcon, The Emerald Cup is ... county fair draws much of California’s original cannabis industry." ...
(Date:11/27/2014)... (PRWEB) November 27, 2014 VeloReality Inc. ... six new Real Life Videos (RLVs) of world-famous velo courses ... Trainer, as well as other popular indoor velo trainers. Two ... available worldwide before the end of November -- in ... the total number of rides in the VeloReality collection to ...
Breaking Medicine News(10 mins):Health News:Aria Health Prepares and Donates 200 Thanksgiving Dinners 2Health News:RBSEO Services Announces SEO Services at $99 Only 2Health News:The Emerald Cup 2014 Competition Partners | CannCast – Bringing You An Up-Close Look At This Year’s Entries and SKUNK Magazine Proudly Sponsoring This Year's Grand Prize 2Health News:The Emerald Cup 2014 Competition Partners | CannCast – Bringing You An Up-Close Look At This Year’s Entries and SKUNK Magazine Proudly Sponsoring This Year's Grand Prize 3Health News:The Emerald Cup 2014 Competition Partners | CannCast – Bringing You An Up-Close Look At This Year’s Entries and SKUNK Magazine Proudly Sponsoring This Year's Grand Prize 4Health News:Winter 2015 Weather Forecast Is Warm and Dry For VeloReality Riders With New RLV Offering 2Health News:Winter 2015 Weather Forecast Is Warm and Dry For VeloReality Riders With New RLV Offering 3
... has released its global status report on alcohol and ... the discussion in the report of the serious health ... which contributes to accidents, many diseases, and premature deaths. ... that the report was limited almost exclusively to abusive ...
... News) -- The immune systems of people with contact allergies ... including breast and brain cancers, new research suggests. Contact ... metals such as nickel. In the new study, researchers ... contact allergies between 1984 and 2008. About one-third (35 percent) ...
... Research to be presented at the upcoming annual ... Behavior (SSIB), the foremost society for research into all ... some antipsychotic drugs can promote overeating, weight gain, and ... by the FDA for the treatment of schizophrenia and ...
... A new method for scoring the severity of illness ... their outcomes, according to researchers at the University of ... in the early online version of Resuscitation, ... out the potential for a patient,s recovery. ...
... , MONDAY, July 11 (HealthDay News) -- Obstructive ... during sleep, plays a role in blood vessel abnormalities ... conditions, a new study suggests. About 15 ... apnea, according to the American Heart Association. The condition ...
... 11 (HealthDay News) -- Many U.S. hospitals don,t follow ... angioplasty and stenting in patients who have a blocked ... finds. A U.S. National Heart, Lung, and Blood ... Trial (OAT), found that angioplasty and stenting -- known ...
Cached Medicine News:Health News:Contact Allergies Associated With Lower Rates of Some Cancers 2Health News:Pitt team finds way to classify post-cardiac arrest patients to better predict outcomes 2Health News:Sleep Apnea Linked to Blood Vessel Disorders in Study 2Health News:Adherence to Angioplasty/Stent Guidelines Lacking: Study 2Health News:Adherence to Angioplasty/Stent Guidelines Lacking: Study 3
... Hycor Biomedical Ltd Autostat™II Rheumatoid Factor IgM ... Rheumatoid Factor IgM (RF IgM). Enzyme-linked immunosorbent ... specific IgM Rheumatoid Factor in human serum. ... can be used as an aid in ...
Rheumatoid Factor , R1: 4 X 20 ml buffer, R2: 2 X 8 ml antibody, Test / Kit: 320 (H717)...
... Scheimpflug Analyzer is a high precision optical ... analysis of the anterior eye segment, based ... and a Placido Disk. , GALILEI combines ... furnishes high accuracy curvature data, while Scheimpflug ...
EXTEND is an absorbable synthetic punctal implant that provides occlusion up to three months. It is packaged 20 implants per box in sizes of .0.3mm, 0.4mm, 0.5mm. A variety pack in also available w...
Medicine Products: